Medical


30
May 14

125 New Jobs at Medical Device Firm

A home-grown medical devices company is taking on 125 new staff in a multimillion-euro expansion in the midlands.

VistaMed is creating the jobs at its plants in Roosky and Carrick-on-Shannon, Co Leitrim, where it has officially opened a new extension to its manufacturing plant.

The firm, which makes catheters and stents which are used by medics in heart surgery, said recruitment has already begun and the positions will be filled by the end of this year.

The seven million-euro expansion has been backed by the taxpayer through Enterprise Ireland, the State investment agency for developing Irish companies.

Jobs Minister Richard Bruton said the investment was a great day for Leitrim and an example for companies around the country of what they can achieve.

“VistaMed is a great example of an Irish company, with world-class product offering, performing strongly in highly competitive global markets and employing large numbers of people in Co Leitrim,

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

14
Apr 14

270 New Jobs for Limerick in €80m Ethicon Biosurgery Investment

Some 270 new jobs have been announced for Limericas part of an €80m investment by Ethicon Biosurgery Ireland.

Ethicon, part of Johnson & Johnson, is a worldwide leader in providing medical patches that help stem blood flow from patients.

The company is to establish a manufacturing facility at the National Technology Park in Plassey.

The new Limerick facility will manufacture EVARREST™ Sealant Matrix, a novel product that rapidly and reliably aids in stopping bleeding during surgery.

Recruitment is underway and the positions will be filled over the next five years.

An additional 150 construction jobs will be created during the construction phase of the project.

The Minister for Jobs Richard Bruton and the Finance Minister Michael Noonan are on hand for the announcement in Limerick this afternoon.

Limerick City and County Council manager Conn Murray said: “The €80m expansion of Ethicon today is a major vote of confidence in Limerick which is fast becoming home to a hub of the leading players in the life sciences and medical devices sectors.

“I welcome the fact that some of the most advanced surgical care in the world, enhancing patients lives across the globe will now be made in Limerick by Limerick people.”

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

21
Feb 14

Jobs Boost for Dublin and Galway as 132 Roles Created

IDA Ireland chief executive Barry and Minister for Jobs, Enterprise & Innovation Richard Bruton. Photo: Alan Betson/The Irish Times Five European and North American tech high growth firms plan expansion.

Over 130 new jobs are to be created in Dublin and Galway by five North American and European high-growth companies.

The new jobs are to be spread across a range of sectors including IT, cyber security, life sciences and financial services.

The companies creating the new jobs are software analytics company New Relic, internet domain name registry business Starting Dot, global consulting company capSpire, manufacturer NeoMed and logistics company SEKO MedTec.

SEKO MedTec is to create 30 jobs in Galway, while New Relic creating 50 new jobs in Dublin. The fast growing software company, based in San Francisco, has selected Dublin as the location for its EMEA headquarters.

NeoMed is also establishing an EMEA headquarters in Dublin with the creation of 22 jobs, while StartingDot is setting up a finance and operations centre in the Capital resulting in 10 new jobs.

Arkansas based company capSpire will create 20 new business consultancy and software development jobs by opening its first international office in Ireland.

IDA Ireland chief executive Barry O’Leary said the IDA has set up a specific division to focus on attracting high-potential, high-growth companies to Ireland at an early stage of their development.

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

23
Oct 13

Irish Firm’s €8m Mexico Deal to Create 30 Jobs

By David YoungA medical diagnostics firm has landed an €8m deal with suppliers in Mexico that will see its products used across the country’s clinics and hospitals.

President Michael D Higgins, who is on an official visit to central America, witnessed the signing of the agreement between Donegal-based Randox Teoranta and Central de Diagnostica e Industria.

The deal to bring the company’s “biochip” lab products to Mexico will create 30 new jobs at its manufacturing facility in Dungloe.

Biochip technology enables numerous tests for diseases, infections, or other substances to be carried out on one single blood sample.

Randox Teoranta is part of Northern Ireland- based Randox Laboratories group, which has been doing business in Mexico for 15 years and has 100 staff in the country.

The trade agreement was signed in the presence of Mr Higgins and Mexico president Enrique Pena Nieto at the Palacio Nacional in Mexico City.

Dr Peter FitzGerald, managing director of Randox Teoranta, said the presence of the heads of state would be a source of pride for the firm.

“We are honoured to have both presidents witness this new trade agreement and of course we are honoured to be working with Mexico,” he said.

“It was one of the first countries in the world to identify the benefits of our unique Biochip technology; it is a very progressive nation, we are a very progressive company, we appreciate this cohesion.

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

4
Jun 13

Inflection aims to raise €8m in financial backing.

 Pictured at the announcement were: Darren Cunningham, Co-Founder and CEO of Inflection Biosciences and Dr Michael O’Neill (with glasses), Co-Founder and Director of Research and Development at Inflection Biosciences.   Pic. Keith Arkins Photography No Repro Fee   Further information: Martha Kavanagh - Drury M:  + 353 87 6462006 Martha.Kavanagh@drury.ieCancer breakthough on the cards for Inflection Biosciences….3-6-13   Dublin based life sciences company Inflection Biosciences Ltd, has announced that it has entered into a license agreement with the world renowned Spanish National Cancer Research Centre (CNIO) for the exclusive, worldwide rights to develop and commercialise a series of innovative new cancer therapeutics.   The company has closed an initial financing round of €450,000 including participation from Enterprise Ireland. Inflection Biosciences and is seeking to raise further investment of up to €8 million over the next three years to help progress an exciting pipeline of potentially ground breaking cancer treatments.   n a deal with the world-leading Spanish National Cancer Research Centre, Inflection will develop drug molecules that could be used to target diseases such as leukaemia, lymphoma and a number of other tumours, such as pancreatic, colorectal and oesophageal cancers.  So-called kinase inhibitors, which regulate proteins associated with those diseases, have demonstrated good activity in early research, according to Inflection, and the treatments can also be taken orally.

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

1
Jun 13

Medtech entrepreneurs taking startups to Ireland.

Irish heritage is deeply rooted in Boston’s cultural history. Over one hundred years after an influx of Irish immigrants seeking opportunity set the tone for Boston’s growth and development, there is a new “innovation exchange,” in which some Boston-based entrepreneurs, particularly those in the medtech sector, are choosing to locate their businesses in Ireland in order to expedite their path to success.

I am a champion of innovation and I am a proud Bostonian. And though I have no familial Irish roots, I found that locating my medtech startups—including Labcoat Ltd, Cappella, and most recently, gEyeCue Ltd—to the Emerald Isle was necessary to achieve my goals.

Here’s why: As a Boston resident with ties to local companies, organizations, and universities (I am a professor at Boston University), I know that relocating businesses across borders is not easy. That said, as much as I love Boston, the medtech community in the U.S. is characterized by long development cycles and costly, complex regulatory processes, making it extremely challenging for entrepreneurs to get their products to market in the US. And with the new medical device tax, moving outside of the U.S. to access the European market is becoming an even more attractive option for medtech entrepreneurs, with 25 percent of medical device company executives admitting to plans to expand overseas in order to deal with the tax, according to a recent study conducted by the Silicon Valley Bank.

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

31
Mar 13

Tech start-up of the week: Portable Medical Technology

Tech start-up of the week: Portable Medical Technology

Portable Medical Technology co-founders Kevin Bambury, Eoin O’Carroll and Dr Richard Bambury

Tech start-up of the week: Portable Medical Technology;

A company that develops accredited and trusted apps for medical specialists to reduce medical errors, improve efficiencies and progress patient communication.

Portable Medical Technology was co-founded by University College Cork (UCC) graduates Kevin Bambury, Eoin O’Carroll and Richard Bambury. The company combines the essential tools specialists need into easy-to-use smartphone and tablet applications that are Food and Drug Administration and CE-approved and provide the latest updated tools to support critical medical decision-making.

Kevin Bambury states: “We set up Portable Medical Technology to develop mobile software to aid clinicians in their day-to-day decision-making. We felt there was a need for safe, validated and specialist-specific apps.”

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

6
Jul 12

InsulCheck raises €350,000 investment and creates 12 jobs

John Phelan, manager of Halo Business Angel Partnership and John Hughes, co-founder and managing director of InsulCheckJohn Phelan, manager of Halo Business Angel Partnership and John Hughes, co-founder and managing director of InsulCheck

Halo Business Angel Partnership (HBAP), the Irish business angel network, has announced that diabetes medical device company InsulCheck has secured investment of €350,000 to facilitate its international growth strategy.

The investment will fund new product development and the creation of 12 jobs over the next two years, bringing the total number of employees to 15.

The investment was facilitated by HBAP, managed by Dublin Business Innovation Centre, and came from multiple sources including HBAP angel investors, AIB Seed Capital Fund and Enterprise Ireland. The new jobs will be in the areas of research and development, design, logistics, and sales and marketing.

InsulCheck was founded in 2009 and officially launched its first product in March 2012. It has developed a small clip-on attachment for insulin pens that automatically records the time since the last injection on a digital display. This provides safety and certainty for insulin pen users, as it removes any doubt around when they last took their injection, an extremely important part of managing their condition.

John Hughes, co-founder and managing director of InsulCheck said: “There are currently 50 million people worldwide who use insulin pens and over 50,000 of those are in Ireland. I myself have diabetes and the inspiration for this device came from an incident in 2008, when I accidently double injected and suffered a hypo-glycaemic event, which resulted in me being hospitalised.

“HBAP and the angel investors have played a crucial role in helping us to understand the medical device market, channels of distribution and to accelerate market penetration. Dublin BIC has also provided us with a lot of guidance in developing and finalising our business plan. As we grow the business, its advice and expertise is invaluable.”

HBAP matches private investors with pre-screened investment opportunities in start-up, early-stage and developing businesses. These business angels provide not only financial support but also deep industry knowledge. HBAP is managed by Dublin BIC and delivered by the regional Irish BICs.

HBAP’s key role was matching InsulCheck with investors, who have expertise in medical sales, marketing and distribution.

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

6
Jul 12

Rosenthal appointed as life sciences start-up ambassador

Rosenthal appointed as life sciences start-up ambassador

Rosenthal appointed as life sciences start-up ambassador

Eddie Goodwin, Enterprise Ireland manager Boston Office, Dr Arthur Rosenthal and Gerry Murphy, Enterprise Ireland executive director, North America

Serial entrepreneur and medical devices expert Dr Arthur Rosenthal has been appointed as Enterprise Ireland’s life sciences start-up ambassador for the US.

Having spent more than 38 years developing medial device technologies Rosenthal is recognised internationally as a leading expert in the field of medical technology.

He will now bring this experience to working closely with Enterprise Ireland to highlight Ireland and what it has to offer for medical and related technology start-ups.

“With its easy access to critical infrastructure, well trained engineers, scientists, universities, and productive labour market, Ireland represents an ideal location for establishing and nurturing medical technology commercialisation,” said Rosenthal.

Eddie Goodwin, VP for life science in the US market for Enterprise Ireland commented:  “Art has direct experience of successfully starting up in Ireland having recently established his third Enterprise Ireland-supported high potential start-up medical devices company in Galway [gEyeCue Medical Systems]. It is a big plus for us to have someone with this track record, based locally in the US who is able to share their experience with other US entrepreneurs.”

Rosenthal’s appointment follows on from earlier appointments of start-up ambassadors for key markets in the UK, China and Middle East.

Late last year, Enterprise Ireland launcheda dedicated €10m International Start-Up Fund to target investor ready overseas entrepreneurs to start their business in Ireland.

The fund is open to company promoters anywhere in the world, but is targeted particularly at the Irish Diaspora, international expatriates, the ‘New Diaspora’ (people from overseas who have previously worked or studied in Ireland), as well as serial and mobile entrepreneurs.

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark

25
May 12

Minister Bruton announces 40 new jobs in Tipperary

Minister Bruton announces 40 new jobs in TipperaryMinister Bruton announces 40 new jobs in Tipperary

Irish medical devices firm Technopath has announced a €3m investment in its quality control division in Tipperary, creating 40 new jobs.

The investment will go towards scaling the firm’s manufacturing capability and drive export activity, supported by Enterprise Ireland.

The quality control division manufactures products for a number of multinational in-vitro diagnostic companies. “Technopath’s breakthrough technology is the culmination of a five-year programme of research and development and €6m investment,” said Technopath co-founder Malcolm Bell. “We have developed a number of proprietary technologies, launching our first product in this division less than four years ago.”

Technopath’s long-term growth strategy is to develop niche, innovative, breakthrough technologies and to deploy these technologies worldwide, bringing the benefit of enhanced quality and cost savings to 20pc of patients around the world in the next two years.

“This is exemplified by our recent global product development, supply and distribution agreement with Abbott Diagnostics,” explained Bell. “Technopath is actively developing a number of additional innovative products for the global biopharmaceutical and dairy sectors that can address the significant un-met needs of these industries.”

“A central part of the Government’s plan for jobs and growth is creating a powerful engine of indigenous enterprise,” said Minister for Jobs, Enterprise and Innovation Richard Bruton, TD. “Over recent years we have established major strengths in key sectors such as ICT and life sciences – we must now build on this to get more indigenous companies growing to scale, exporting more and creating more jobs.”

Read [+]

  • Facebook
  • Twitter
  • LinkedIn
  • Google Bookmarks
  • Share/Bookmark